ヘモクロマトーシス
Lawrie W Powell1, Rebecca C Seckington2, Yves Deugnier3
1Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane, Australia.
Lancet (London, England)
|March 16, 2016
まとめ
遺伝性血色腫は,低濃度のヘプシジンによって引き起こされる鉄過負荷疾患です. 遺伝子と環境要因を理解することで 診断と治療が改善され 平均寿命が延びられるのです
科学分野:
- 遺伝子 と 代謝
- 胃腸科と肝臓科
背景:
- 遺伝性血色腫は,ヘプシディンの不十分な生産によって特徴づけられる遺伝的な鉄貯蔵疾患です.
- 組織損傷や臓器不全を引き起こす.
- 重度の肝疾患から無症状の症例までの可変な臨床表現は,診断上の課題を提示する.
研究 の 目的:
- 遺伝的血色変異の遺伝的異質性と一般的な代謝経路を探求する.
- 病気の変化する臨床表現に影響を与える要因を調査する.
- 早期診断と現在の治療戦略の重要性を強調する.
主な方法:
- 遺伝性血色腫の遺伝学と病理学に関する既存の文献のレビュー.
- 環境の影響や遺伝子を改変するなど,フェノタイプの変化に寄与する要因の分析.
- 診断方法と治療結果の評価
主要な成果:
- 不適切な低ヘプシディン生成の共通経路を 異なる遺伝子形態で特定した.
- アルコールの消費や遺伝子の変異などの環境要因の役割を強調した.
- 早期診断と前症候群治療により 平均寿命が延びることが確認されました
結論:
- 遺伝性血色腫の治療には,早期診断のための高い疑い指数が必要です.
- 病気の進行を予測するのに 遺伝的および環境的変異因子を理解することは 極めて重要です
- 静脈切開は主要な治療法であり,代替治療法に関する研究が進行中です.
さらに関連する動画
関連する概念動画
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
611
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
724
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
724
01:16Necrosis
7.1K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.1K
01:27Disorders of Erythrocytes
2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
01:28The Early Endosome: Endocytosis of Transferrin
5.1K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.1K
01:26Diseases of the Liver and Gallbladder
2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K